TY - JOUR
T1 - An enzyme-linked immunosorbent assay for subtypic determinants of hepatitis B surface antigen with monoclonal antibodies
AU - Ikeda, Hiroshi
AU - Iwasaki, Yoshiaki
AU - Nouso, Kazuhiro
AU - Takaguchi, Kouichi
AU - Tsuji, Takao
N1 - Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1990
Y1 - 1990
N2 - An enzyme-linked immunosorbent assay (ELISA) was developed to detect subtypic determinants (d, y, w and r) of hepatitis B surface antigen (HBsAg) with monoclonal antibodies in a total of 182 sera of 91 HBsAg positive asymptomatic carriers (ASC, mean age ; 18 years old) and 91 HBsAg positive patients with chronic liver disease (CH, mean age : 33 years old) in Japan. In 91 ASC, the number of adr was 68 (74.7%), that of adw was 18 (19.8%), that of ayw was 2 (2.2%), and that of adwr was 3 (3.3%). In 91 CH, the number of adr was 88 (96.7%), that of adw was 1 (1.1%), that of adyr was 1 (1.1%), and that of adwr was 1 (1.1%). Thirty-six (52.9%) in 68 ASC of adr were positive anti-HBe. In contrast, 14 (77.8%) in 18 ASC of adw were positive anti-HBe. In five (5.7%) in 88 CH of adr, the subtype of adr changed to adwr in acute exacerbation. The quantitive level of subtypic determinant w reached its peak before the peak of serum transaminase, parallel to the quantitive level of HBsAg and binding activity of polymerized human serum albumin receptor on hepatitis B virus particles and DNA-polymerase activity. However, the number of adwr in 91 ASC was 3 (3.3%) with normal level of the serum transaminase. These results suggest that HBsAg positive carriers of adw seem to become positive anti-HBe earlier than HBsAg positive carriers of adr, and that the compound subtype of adwr doesn't always seem to be associated with liver damage.
AB - An enzyme-linked immunosorbent assay (ELISA) was developed to detect subtypic determinants (d, y, w and r) of hepatitis B surface antigen (HBsAg) with monoclonal antibodies in a total of 182 sera of 91 HBsAg positive asymptomatic carriers (ASC, mean age ; 18 years old) and 91 HBsAg positive patients with chronic liver disease (CH, mean age : 33 years old) in Japan. In 91 ASC, the number of adr was 68 (74.7%), that of adw was 18 (19.8%), that of ayw was 2 (2.2%), and that of adwr was 3 (3.3%). In 91 CH, the number of adr was 88 (96.7%), that of adw was 1 (1.1%), that of adyr was 1 (1.1%), and that of adwr was 1 (1.1%). Thirty-six (52.9%) in 68 ASC of adr were positive anti-HBe. In contrast, 14 (77.8%) in 18 ASC of adw were positive anti-HBe. In five (5.7%) in 88 CH of adr, the subtype of adr changed to adwr in acute exacerbation. The quantitive level of subtypic determinant w reached its peak before the peak of serum transaminase, parallel to the quantitive level of HBsAg and binding activity of polymerized human serum albumin receptor on hepatitis B virus particles and DNA-polymerase activity. However, the number of adwr in 91 ASC was 3 (3.3%) with normal level of the serum transaminase. These results suggest that HBsAg positive carriers of adw seem to become positive anti-HBe earlier than HBsAg positive carriers of adr, and that the compound subtype of adwr doesn't always seem to be associated with liver damage.
KW - ELISA
KW - HBV-pAR activity
KW - HBsAg subtype
KW - compound subtype
KW - hepatitis B virus
UR - http://www.scopus.com/inward/record.url?scp=85004204764&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85004204764&partnerID=8YFLogxK
U2 - 10.2177/jsci.13.65
DO - 10.2177/jsci.13.65
M3 - Article
AN - SCOPUS:85004204764
VL - 13
SP - 65
EP - 71
JO - Immunological Medicine
JF - Immunological Medicine
SN - 0911-4300
IS - 1
ER -